Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib.

Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib.

<h4>Purpose</h4>To compare the effectiveness of octreotide/everolimus vs. sunitinib for the systemic treatment of recurrent aggressive meningiomas.<h4>Methods</h4>31 patients with recurrent or refractory WHO II or WHO III meningiomas were examined in two reference centers in...

Full description

Bibliographic Details
Main Authors: Andrés F Cardona, Alejandro Ruiz-Patiño, Zyanya Lucia Zatarain-Barrón, Fernando Hakim, Enrique Jiménez, Juan Armando Mejía, Juan Fernando Ramón, Nicolás Useche, Sonia Bermúdez, Diego Pineda, Hernando Cifuentes, Leonardo Rojas, Luisa Ricaurte, Luis Eduardo Pino, Carmen Balaña, Oscar Arrieta
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0217340

Internet

https://doi.org/10.1371/journal.pone.0217340

Similar Items